3 Newly Listed Biotech Stocks – And A Look At Their Market Debuts

Three biotech companies developing therapies for the treatment of cancer and other diseases – including infectious diseases like COVID-19 – began trading on Friday. Among the firms making their market debut was C4 Therapeutics, which today’s article notes “is developing therapeutic candidates to treat cancer, neurodegenerative conditions and other diseases”. For more on these newly listed biotech stocks and their early performance, CLICK HERE.